Balazs Acs

27PUBLICATIONS
137CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersTumour immunologyDisease surveillanceInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Apr 08, 2026
Neoadjuvant palbociclib and endocrine therapy versus chemotherapy in ER + /HER2- breast cancer: a randomized phase II trial.

Alexios Matikas, Evangelos Tzoras, Michail Sarafidis

|Feb 05, 2026
Making sense of TILs: recommendations for morphological assessment of tumour-infiltrating lymphocytes in gastro-oesophageal carcinoma: A report on behalf of the International Immuno-Oncology Biomarker Working Group.

Ylva A Weeda, Roberto Salgado, Filip van Herpe

|Mar 07, 2025
Machine learning-based spatial characterization of tumor-immune microenvironment in the EORTC 10994/BIG 1-00 early breast cancer trial.

Ioannis Zerdes, Alexios Matikas, Artur Mezheyeuski

|Feb 28, 2025
A bottom-up initiated digital external quality assessment scheme for the state-of-the-art pathology in Sweden: reduced variability between pathology departments.

Gunilla Rask, Helena Olofsson, Annette Bauer

|Jun 28, 2024
A population-based study on trajectories of HER2 status during neoadjuvant chemotherapy for early breast cancer and metastatic progression.

Caroline Boman, Xingrong Liu, Louise Eriksson Bergman

|Feb 23, 2024
Immune cell infiltrate in ductal carcinoma in situ and the risk of dying from breast cancer: case-control study.

Gunilla Rask, Charlotta Wadsten, Balazs Acs

Pageof 5

Frequent Collaborators

10 joint publications

Johan Hartman

9 joint publications

David Rimm

5 joint publications

Theodoros Foukakis

4 joint publications

Alexios Matikas